These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10225571)

  • 1. Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.
    Birmingham MC; Guarino R; Heller A; Wilton JH; Shah A; Hejmanowski L; Nix DE; Schentag JJ
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():43-8. PubMed ID: 10225571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients.
    Haraguchi S; Hioki M; Yamashita K; Orii K; Yamashita Y; Kawamura J; Takushima M; Endo N; Koizumi K; Shimizu K
    Surg Today; 2007; 37(4):282-4. PubMed ID: 17387558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pharmacokinetics of ciprofloxacin in goats.
    García Ovando H; Gorla N; Poloni G; Trotti N; Prieto G; Errecalde C
    Int J Antimicrob Agents; 2000 Jun; 15(1):77-9. PubMed ID: 10856681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
    Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L
    Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing.
    Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R
    J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
    Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
    Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric absorption of ciprofloxacin during tube feeding in the critically ill.
    Cohn SM; Sawyer MD; Burns GA; Tolomeo C; Milner KA
    J Antimicrob Chemother; 1996 Nov; 38(5):871-6. PubMed ID: 8961058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
    Rohwedder R; Bergan T; Caruso E; Thorsteinsson SB; Della Torre H; Scholl H
    Chemotherapy; 1991; 37(4):229-38. PubMed ID: 1790720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of pefloxacin and ciprofloxacin into lung tissue.
    Scaglione F; Mezzetti M; Arcidiacono MM; Gattei G; Fraschini F
    J Antimicrob Chemother; 1995 Apr; 35(4):557-9. PubMed ID: 7628993
    [No Abstract]   [Full Text] [Related]  

  • 18. Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.
    Joukhadar C; Klein N; Frossard M; Minar E; Stass H; Lackner E; Herrmann M; Riedmüller E; Müller M
    Clin Pharmacol Ther; 2001 Dec; 70(6):532-9. PubMed ID: 11753269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin in eels by high-performance liquid chromatography with fluorescence detection.
    Guo L; Xie Z; Lin X; Wu X; Qiu B; Zhang Y; You H; Chen G
    Anal Biochem; 2005 Jun; 341(2):275-9. PubMed ID: 15907873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection.
    Sowinski KM; Kays MB
    J Clin Pharm Ther; 2004 Aug; 29(4):381-7. PubMed ID: 15271106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.